Phase I/II study of gemcitabine and exisulind as second-line therapy in patients with advanced non-small cell lung cancer

Tien Hoang, Kyungmann Kim, Joseph Merchant, Anne M. Traynor, James McGovern, Kurt R. Oettel, Fredrico A. Sanchez, Harish G. Ahuja, Thomas A. Hensing, Martha Larson, Joan H. Schiller

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I/II study of gemcitabine and exisulind as second-line therapy in patients with advanced non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences